Lioton

Heparin Sodium, the active ingredient in Lioton, is an anticoagulant presented as a cutaneous preparation for topical use. It helps prevent clot formation in patients undergoing surgical procedures, dialysis, or requiring catheter maintenance, including those with cardiovascular risk factors.

GNH USA supplies Lioton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for global distribution and supports clinical outcomes through consistent supply.

Lioton (heparin sodium) is used as an anticoagulant to prevent thrombosis in various clinical settings.

- Surgical prophylaxis: prevents intra‑operative clot formation during operative procedures. - Hemodialysis circuit: maintains patency of the extracorporeal circuit during dialysis sessions. - Catheter maintenance: reduces risk of line‑associated thrombosis for indwelling catheters.

Heparin Sodium may cause local and systemic adverse reactions when applied cutaneously.

Common Side Effects: - Bruising at the application site. - Local erythema or redness. - Itching or mild skin irritation. - Minor bleeding or oozing. - Pain or tenderness where applied. - Swelling of the surrounding tissue.

Serious or Rare Side Effects: - Severe or uncontrolled bleeding. - Heparin‑induced thrombocytopenia (HIT). - Allergic reaction or anaphylaxis. - Skin necrosis at the site of application. - Systemic anticoagulation leading to hemorrhage. - Paradoxical thrombosis despite therapy.

When using Lioton, several precautions should be observed to minimize bleeding risk and other complications.

- Assess bleeding risk: evaluate patient history of hemorrhage before application. - Monitor platelet count: watch for heparin‑induced thrombocytopenia during therapy. - Avoid in active bleeding: do not apply to open wounds or areas with uncontrolled bleeding. - Use with caution in renal impairment: adjust monitoring as clearance may be affected. - Pregnancy: consult an obstetrician before use in pregnant or breastfeeding patients. - Store below 25°C: keep in the original pack, protect from moisture.

Heparin Sodium can interact with other medications, affecting its anticoagulant activity.

Major Interactions (Avoid): - Concurrent use with other anticoagulants (e.g., warfarin, direct oral anticoagulants): increased bleeding risk. - Thrombolytic agents (e.g., alteplase): additive anticoagulant effect. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of gastrointestinal bleeding.

Moderate Interactions (Monitor Closely): - Antiplatelet agents (e.g., aspirin, clopidogrel): monitor for excessive bleeding. - Corticosteroids: may increase skin fragility and bruising. - Heparin‑binding proteins (e.g., protamine): may alter efficacy of heparin.